BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 36813149)

  • 21. STAT3-induced lncRNA HAGLROS overexpression contributes to the malignant progression of gastric cancer cells via mTOR signal-mediated inhibition of autophagy.
    Chen JF; Wu P; Xia R; Yang J; Huo XY; Gu DY; Tang CJ; De W; Yang F
    Mol Cancer; 2018 Jan; 17(1):6. PubMed ID: 29329543
    [TBL] [Abstract][Full Text] [Related]  

  • 22. miR-199a and miR-199b facilitate diffuse gastric cancer progression by targeting Frizzled-6.
    Hong SA; Lee S; Park J; Hong M; Yoon JS; Lee H; Lee JH; Kim S; Won HS; Kang K; Ko YH; Ahn YH
    Sci Rep; 2023 Oct; 13(1):17480. PubMed ID: 37838767
    [TBL] [Abstract][Full Text] [Related]  

  • 23. M2 macrophage-derived extracellular vesicles promote gastric cancer progression via a microRNA-130b-3p/MLL3/GRHL2 signaling cascade.
    Zhang Y; Meng W; Yue P; Li X
    J Exp Clin Cancer Res; 2020 Jul; 39(1):134. PubMed ID: 32660626
    [TBL] [Abstract][Full Text] [Related]  

  • 24. miR-199a-3p targets ETNK1 to promote invasion and migration in gastric cancer cells and is associated with poor prognosis.
    Li L; Mou YP; Wang YY; Wang HJ; Mou XZ
    Pathol Res Pract; 2019 Sep; 215(9):152511. PubMed ID: 31255331
    [TBL] [Abstract][Full Text] [Related]  

  • 25. miR-199a-3p targets stemness-related and mitogenic signaling pathways to suppress the expansion and tumorigenic capabilities of prostate cancer stem cells.
    Liu R; Liu C; Zhang D; Liu B; Chen X; Rycaj K; Jeter C; Calhoun-Davis T; Li Y; Yang T; Wang J; Tang DG
    Oncotarget; 2016 Aug; 7(35):56628-56642. PubMed ID: 27447749
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeted delivery of microRNA-199a-3p using self-assembled dipeptide nanoparticles efficiently reduces hepatocellular carcinoma in mice.
    Varshney A; Panda JJ; Singh AK; Yadav N; Bihari C; Biswas S; Sarin SK; Chauhan VS
    Hepatology; 2018 Apr; 67(4):1392-1407. PubMed ID: 29108133
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MicroRNA-199a-3p is downregulated in gastric carcinomas and modulates cell proliferation.
    Peng W; Chen ZY; Wang L; Wang Z; Li J
    Genet Mol Res; 2013 Aug; 12(3):3038-47. PubMed ID: 24065659
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MicroRNA-495-3p inhibits multidrug resistance by modulating autophagy through GRP78/mTOR axis in gastric cancer.
    Chen S; Wu J; Jiao K; Wu Q; Ma J; Chen D; Kang J; Zhao G; Shi Y; Fan D; Zhao G
    Cell Death Dis; 2018 Oct; 9(11):1070. PubMed ID: 30341283
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Silence of lncRNA HEIH suppressed liver cancer cell growth and metastasis through miR-199a-3p/mTOR axis.
    Ma Y; Cao D; Li G; Hu J; Liu X; Liu J
    J Cell Biochem; 2019 Oct; 120(10):17757-17766. PubMed ID: 31144384
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exosomal transfer of miR-15b-3p enhances tumorigenesis and malignant transformation through the DYNLT1/Caspase-3/Caspase-9 signaling pathway in gastric cancer.
    Wei S; Peng L; Yang J; Sang H; Jin D; Li X; Chen M; Zhang W; Dang Y; Zhang G
    J Exp Clin Cancer Res; 2020 Feb; 39(1):32. PubMed ID: 32039741
    [TBL] [Abstract][Full Text] [Related]  

  • 31. miR-3065-3p promotes stemness and metastasis by targeting CRLF1 in colorectal cancer.
    Li Y; Xun J; Wang B; Ma Y; Zhang L; Yang L; Gao R; Guan J; Liu T; Gao H; Wang X; Zhang Q
    J Transl Med; 2021 Oct; 19(1):429. PubMed ID: 34656128
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of miRNomes in human stomach and gastric carcinoma reveals miR-133b/a-3p as therapeutic target for gastric cancer.
    Liu Y; Zhang X; Zhang Y; Hu Z; Yang D; Wang C; Guo M; Cai Q
    Cancer Lett; 2015 Dec; 369(1):58-66. PubMed ID: 26276722
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MiR-199a-3p promotes gastric cancer progression by targeting ZHX1.
    Wang Z; Ma X; Cai Q; Wang X; Yu B; Cai Q; liu B; Zhu Z; Li C
    FEBS Lett; 2014 Nov; 588(23):4504-12. PubMed ID: 25448600
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Knockdown of linc00152 inhibits the progression of gastric cancer by regulating microRNA-193b-3p/ETS1 axis.
    Wang H; Chen W; Yang P; Zhou J; Wang K; Tao Q
    Cancer Biol Ther; 2019; 20(4):461-473. PubMed ID: 30404587
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ascitic fluid shear stress in concert with hepatocyte growth factor drive stemness and chemoresistance of ovarian cancer cells via the c-Met-PI3K/Akt-miR-199a-3p signaling pathway.
    Hassan AA; Artemenko M; Tang MKS; Shi Z; Chen LY; Lai HC; Yang Z; Shum HC; Wong AST
    Cell Death Dis; 2022 Jun; 13(6):537. PubMed ID: 35676254
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MiR-675 is frequently overexpressed in gastric cancer and enhances cell proliferation and invasion via targeting a potent anti-tumor gene PITX1.
    Liu L; Tian YC; Mao G; Zhang YG; Han L
    Cell Signal; 2019 Oct; 62():109352. PubMed ID: 31260797
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The hypoxia-related microRNA miR-199a-3p displays tumor suppressor functions in ovarian carcinoma.
    Kinose Y; Sawada K; Nakamura K; Sawada I; Toda A; Nakatsuka E; Hashimoto K; Mabuchi S; Takahashi K; Kurachi H; Lengyel E; Kimura T
    Oncotarget; 2015 May; 6(13):11342-56. PubMed ID: 25839163
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MicroRNA-642b-3p functions as an oncomiR in gastric cancer by down-regulating the CUB and sushi multiple domains protein 1/smad axis.
    Liu H; Chen Y; Zhou L; Jiang X; Zhou X
    Bioengineered; 2022 Apr; 13(4):9613-9627. PubMed ID: 35412956
    [TBL] [Abstract][Full Text] [Related]  

  • 39. miR-92a-3p promotes the proliferation and invasion of gastric cancer cells by targeting KLF2.
    Mao QQ; Chen JJ; Xu WJ; Zhao XZ; Sun X; Zhong L
    J Biol Regul Homeost Agents; 2020; 34(4):1333-1341. PubMed ID: 32907305
    [TBL] [Abstract][Full Text] [Related]  

  • 40. miR-148b-3p inhibits gastric cancer metastasis by inhibiting the Dock6/Rac1/Cdc42 axis.
    Li X; Jiang M; Chen D; Xu B; Wang R; Chu Y; Wang W; Zhou L; Lei Z; Nie Y; Fan D; Shang Y; Wu K; Liang J
    J Exp Clin Cancer Res; 2018 Mar; 37(1):71. PubMed ID: 29587866
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.